20/20 Biolabs公司近日推出了其创新产品——Onetest。该产品是一款集长寿血液检测与慢性疾病风险评估及管理于一体的综合解决方案。值得注意的是，此解决方案的核心能力构建于IBM先进的人工智能技术之上。
20/20 Biolabs公司近日推出了其创新产品——Onetest。该产品是一款集长寿血液检测与慢性疾病风险评估及管理于一体的综合解决方案。值得注意的是，此解决方案的核心能力构建于IBM先进的人工智能技术之上。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.